When and how should atrial septal defects be closed in adults?
In this review, evidence is presented to indicate that hemodynamically significant (right ventricular volume overload) atrial septal defects (ASDs) in adults should be transcatheter occluded, irrespective of symptomatology. While surgical closure is safe and effective, device closure carries less morbidity. Several devices have been investigated over the last few decades, but at the present time, only two devices, namely, the Amplatzer and the Helex, have received FDA approval; the former is useful in most defects, while the latter is useful in small- and medium-sized defects. A detailed description of Amplatzer device implantation is presented. Finally, approaches to occlude ASDs with complex anatomy are reviewed.
Rao
P Syamasundar
PS
Division of Pediatric Cardiology, UT-Houston Medical School/Memorial Hermann Children's Hospital, Houston, TX 77030, USA. P.Syamasundar.Rao@uth.tmc.edu
D000328:Adult; D000367:Age Factors; D003657:Decision Making; D004621:Embolization, Therapeutic / Q000379:methods*; D006344:Heart Septal Defects, Atrial / Q000628:therapy*; D006801:Humans; D013997:Time Factors; D016896:Treatment Outcome